Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-27 23:45 | 2017-03-23 | HOFD | N/A | LEUCADIA NATIONAL CORP | 10% owner | Other | BUY | $39.95 | 783,889 | $31,316,366 | 10,838,115 | +7.8% |
| 2017-03-27 17:08 | 2017-03-24 | N-A | N/A | STRS OHIO | 10% owner | Other | BUY | $15.00 | 400,000 | $6,000,000 | 12,775,530 | +3.2% |
| 2017-03-28 03:58 | 2017-03-23 | ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | Deer Park Road Management Company, LP | 10% owner | Services-Miscellaneous Business Services | BUY | $28.15 | 43,404 | $1,221,823 | 1,580,679 | +2.8% |
| 2017-03-28 01:02 | 2017-03-27 | VTL | IMMUNIC, INC. | Satter Muneer A | Director, 10% owner | Pharmaceutical Preparations | BUY | $4.00 | 3,750,000 | $15,000,000 | 10,882,277 | +52.6% |
| 2017-03-28 01:06 | 2017-03-23 | FSC | Oaktree Specialty Lending Corp | TANNENBAUM LEONARD M | 10% owner | Other | BUY | $4.67 | 655,850 | $3,060,065 | 655,850 | +100.0% |
| 2017-03-27 23:15 | 2017-03-23 | LJPC | N/A | TANG KEVIN C | Director, 10% owner | Other | BUY | $33.50 | 149,254 | $5,000,009 | 3,440,419 | +4.5% |
| 2017-03-27 21:52 | 2017-03-22 | GNMX | N/A | HARPER PHILIP R | 10% owner | Other | BUY | $1.78 | 1,058,531 | $1,883,656 | 4,845,213 | +28.0% |
| 2017-03-28 00:46 | 2017-03-23 | SHLD | N/A | FAIRHOLME CAPITAL MANAGEMENT LLC | Director, 10% owner | Other | BUY | $8.13 | 286,600 | $2,329,743 | 28,843,748 | +1.0% |
| 2017-03-24 17:00 | 2017-03-22 | CALA | Calithera Biosciences Inc. | ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% owner | Pharmaceutical Preparations | BUY | $10.25 | 487,804 | $4,999,991 | 4,122,873 | +13.4% |
| 2017-03-25 02:30 | 2017-03-22 | SHLD | N/A | LAMPERT EDWARD S | Director, Officer, 10% owner - Chief Executive Officer | Other | BUY | $7.93 | 525,936 | $4,172,093 | 31,842,833 | +1.7% |
| 2017-03-24 00:29 | 2017-03-22 | AMH | American Homes 4 Rent | HUGHES B WAYNE ET AL | Director | Real Estate Investment Trusts | BUY | $22.80 | 2,192,982 | $49,999,990 | 10,412,235 | +26.7% |
| 2017-03-24 01:26 | 2017-03-21 | RCII | UPBOUND GROUP, INC. | Engaged Capital LLC | 10% owner | Services-Equipment Rental & Leasing, NEC | BUY | $8.65 | 1,695,233 | $14,658,341 | 3,390,148 | +100.0% |
| 2017-03-24 00:06 | 2017-03-21 | IPI | Intrepid Potash, Inc. | HARVEY HUGH E JR | Director | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | BUY | $1.20 | 3,233,332 | $3,879,998 | 11,751,383 | +38.0% |
| 2017-03-24 00:06 | 2017-03-21 | IPI | Intrepid Potash, Inc. | Jornayvaz Robert P III | Director, Officer, 10% owner - Exec. Chair, President & CEO | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | BUY | $1.20 | 6,300,000 | $7,560,000 | 18,034,122 | +53.7% |
| 2017-03-24 03:28 | 2017-03-23 | TNDM | TANDEM DIABETES CARE INC | BLICKENSTAFF KIM D | Director, Officer - PRESIDENT & CEO | Surgical & Medical Instruments & Apparatus | BUY | $1.25 | 1,600,000 | $2,000,000 | 2,007,939 | +392.2% |
| 2017-03-24 00:55 | 2017-03-21 | FSC | Oaktree Specialty Lending Corp | TANNENBAUM LEONARD M | 10% owner | Other | BUY | $4.64 | 477,484 | $2,213,473 | 15,246,743 | +3.2% |
| 2017-03-23 21:30 | 2017-03-16 | PRAA | PRA GROUP INC | Olsen Geir | Director | Short-Term Business Credit Institutions | BUY | $34.84 | 143,000 | $4,982,792 | 143,000 | +100.0% |
| 2017-03-24 00:07 | 2017-03-21 | IPI | Intrepid Potash, Inc. | MARTIN J LANDIS | Director | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | BUY | $1.20 | 3,150,000 | $3,780,000 | 3,233,709 | +3,763.0% |
| 2017-03-23 04:19 | 2017-03-20 | MYAN | Emmaus Life Sciences, Inc. | RSJ Investments SICAV a.s. | 10% owner | Pharmaceutical Preparations | BUY | $6.25 | 160,000 | $1,000,000 | 625,704 | +34.4% |
| 2017-03-23 00:28 | 2017-03-21 | RDUS | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $35.83 | 50,000 | $1,791,625 | 4,540,399 | +1.1% |
| 2017-03-23 01:50 | 2017-03-20 | SHLD | N/A | FAIRHOLME CAPITAL MANAGEMENT LLC | Director, 10% owner | Other | BUY | $8.17 | 613,900 | $5,017,343 | 28,557,148 | +2.2% |
| 2017-03-22 22:34 | 2017-03-20 | SAH | SONIC AUTOMOTIVE INC | SMITH O BRUTON | Director, Officer, 10% owner - Executive Chairman | Retail-Auto Dealers & Gasoline Stations | BUY | $20.14 | 100,000 | $2,014,240 | 668,494 | +17.6% |
| 2017-03-22 01:47 | 2017-03-17 | VIVE | N/A | Atkinson James G. | Director - CBO & President | Other | BUY | $4.00 | 375,000 | $1,500,000 | 285,599 | +100.0% |
| 2017-03-22 02:23 | 2017-03-17 | TSLA | Tesla, Inc. | Musk Elon | Director, Officer, 10% owner - CEO | Motor Vehicles & Passenger Car Bodies | BUY | $262.00 | 95,420 | $25,000,040 | 33,599,088 | +0.3% |
| 2017-03-22 00:22 | 2017-03-17 | VIVE | N/A | Stonepine Capital Management, LLC | Director, 10% owner | Other | BUY | $4.00 | 1,250,000 | $5,000,000 | 3,849,711 | +48.1% |
| 2017-03-21 19:31 | 2017-03-17 | RDUS | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $38.41 | 30,000 | $1,152,249 | 4,490,399 | +0.7% |
| 2017-03-22 00:22 | 2017-03-17 | FSC | Oaktree Specialty Lending Corp | TANNENBAUM LEONARD M | 10% owner | Other | BUY | $4.62 | 345,000 | $1,592,313 | 14,769,259 | +2.4% |
| 2017-03-22 01:48 | 2017-03-17 | VIVE | N/A | JANNEY DANIEL | Director | Other | BUY | $4.00 | 500,000 | $2,000,000 | 1,381,955 | +56.7% |
| 2017-03-21 23:21 | 2017-03-20 | TRNC | N/A | SOON-SHIONG PATRICK | Director, 10% owner | Other | BUY | $14.87 | 2,950,000 | $43,870,040 | 7,650,000 | +62.8% |
| 2017-03-21 00:02 | 2017-03-17 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $131.03 | 100,000 | $13,102,820 | 8,655,653 | +1.2% |
| 2017-03-21 04:51 | 2017-03-16 | PRAA | PRA GROUP INC | Olsen Geir | Director | Short-Term Business Credit Institutions | BUY | $34.84 | 143,000 | $4,981,434 | 143,000 | +100.0% |
| 2017-03-21 04:50 | 2017-03-16 | PLSE | PULSE BIOSCIENCES, INC. | DUGGAN ROBERT W | 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $23.56 | 205,127 | $4,831,931 | 2,378,486 | +9.4% |
| 2017-03-20 23:05 | 2017-03-17 | ADI | Analog Devices, Inc. | EVANS BRUCE R | Director | Semiconductors & Related Devices | BUY | $83.12 | 25,000 | $2,078,000 | 53,540 | +87.6% |
| 2017-03-18 01:02 | 2017-02-01 | LAUR | LAUREATE EDUCATION, INC. | COHEN STEVEN A/SAC CAPITAL MGMT LP | 10% owner | Services-Educational Services | BUY | $13.08 | 602,864 | $7,887,089 | 602,864 | +100.0% |
| 2017-03-17 20:01 | 2017-03-16 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $128.38 | 70,000 | $8,986,565 | 8,555,653 | +0.8% |
| 2017-03-17 23:37 | 2017-03-17 | EQS | EQUUS TOTAL RETURN, INC. | Hardy John A. | Director, Officer - Chief Executive Officer | Other | BUY | $2.40 | 500,000 | $1,200,000 | 500,000 | +100.0% |
| 2017-03-18 03:42 | 2017-03-15 | N/A | Whitehawk Therapeutics, Inc. | Khuong Chau Quang | Director, 10% owner | Pharmaceutical Preparations | BUY | $5.00 | 762,995 | $3,814,975 | 4,416,446 | +20.9% |
| 2017-03-17 23:32 | 2017-03-15 | KIN | N/A | Park West Asset Management LLC | 10% owner | Other | BUY | $6.60 | 400,000 | $2,640,000 | 4,386,404 | +10.0% |
| 2017-03-18 03:42 | 2017-03-15 | N/A | Whitehawk Therapeutics, Inc. | Castelein Caley | Director | Pharmaceutical Preparations | BUY | $5.00 | 400,000 | $2,000,000 | 1,611,408 | +33.0% |
| 2017-03-18 02:34 | 2017-03-15 | N/A | Whitehawk Therapeutics, Inc. | Satter Muneer A | Director, 10% owner | Pharmaceutical Preparations | BUY | $5.00 | 1,120,000 | $5,600,000 | 3,241,835 | +52.8% |
| 2017-03-17 23:16 | 2017-03-15 | ARLZ | N/A | ADAMS ADRIAN | Director, Officer - Chief Executive Officer | Other | BUY | $2.46 | 500,000 | $1,230,950 | 3,569,230 | +16.3% |
| 2017-03-18 03:37 | 2017-03-15 | N/A | Whitehawk Therapeutics, Inc. | WEISS PAUL M | Director | Pharmaceutical Preparations | BUY | $5.00 | 272,302 | $1,361,510 | 1,576,167 | +20.9% |
| 2017-03-17 23:32 | 2017-03-15 | FSC | Oaktree Specialty Lending Corp | TANNENBAUM LEONARD M | 10% owner | Other | BUY | $4.51 | 1,273,000 | $5,741,230 | 14,424,259 | +9.7% |
| 2017-03-18 03:36 | 2017-03-15 | N/A | Whitehawk Therapeutics, Inc. | Novartis Bioventures Ltd | 10% owner | Pharmaceutical Preparations | BUY | $5.00 | 560,000 | $2,800,000 | 5,805,550 | +10.7% |
| 2017-03-18 00:22 | 2017-03-15 | SHLD | N/A | FAIRHOLME CAPITAL MANAGEMENT LLC | Director, 10% owner | Other | BUY | $8.79 | 222,100 | $1,952,637 | 27,982,348 | +0.8% |
| 2017-03-18 03:40 | 2017-03-15 | N/A | Whitehawk Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $5.00 | 762,995 | $3,814,975 | 4,416,446 | +20.9% |
| 2017-03-16 22:47 | 2017-03-15 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $127.31 | 70,000 | $8,911,700 | 8,485,653 | +0.8% |
| 2017-03-17 01:30 | 2017-03-14 | DKL | Delek Logistics Partners, LP | Delek US Holdings, Inc. | 10% owner | Pipe Lines (No Natural Gas) | BUY | $29.97 | 34,722 | $1,040,455 | 15,151,375 | +0.2% |
| 2017-03-16 23:31 | 2017-03-14 | VRX | Bausch Health Companies Inc. | ValueAct Holdings, L.P. | Director, Other | Pharmaceutical Preparations | BUY | $10.82 | 3,000,000 | $32,465,100 | 16,937,431 | +21.5% |
| 2017-03-16 23:42 | 2017-03-14 | RDUS | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $39.97 | 61,721 | $2,466,871 | 4,460,399 | +1.4% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.